当前位置： SCI文献检索 > PEDIATRIC BLOOD & CANCER期刊下所有文献 > Weight and height in children newly diagnosed with cancer.

Weight and height in children newly diagnosed with cancer.

Abstract：

BACKGROUND:Although weight loss and lack of linear growth occur in children with cancer, growth history is not included in research that aims to determine nutritional status in children newly diagnosed with cancer. Therefore, this study aimed to determine weight loss and lack of linear growth in this patient group. PROCEDURE:Weight and height were recorded in 95 children (ages 1.5-10 years) at diagnosis and compared with data predicted from growth curves. Age, gender, type of malignancy, extent of disease, and prior weight and height were tested for their potential relation to differences between actual and predicted data. RESULTS:The incidence of undernutrition, based on z-scores for weight-for-age (WFA), height-for-age (HFA), and weight-for-height (WFH), was 2%, 4%, and 7%, respectively. Actual z-scores were lower than predicted z-scores. Differences between actual and predicted z-scores of <-0.5 standard deviation score (SDS) in WFA, HFA, or WFH were found in 25%, 23%, and 29% of the children, respectively. Children with advanced cancer had the highest risk of significant weight loss (<-0.5 SDS in WFA) (ORWFA  = 3.45, P = 0.012) prior to diagnosis. Differences were unrelated to type of malignancy, age, gender, and weight and height prior to diagnosis. CONCLUSIONS:At diagnosis, approximately 25% of the children showed a significant reduction in z-scores for weight-for-age, height-for-age, and weight-for-height. This reduction may indicate a deteriorated nutritional status. Therefore, assessment of growth history should be standard of care to ensure appropriate nutritional interventions and should be included in research that aims to evaluate nutritional status in children newly diagnosed with cancer. Pediatr Blood Cancer 2015;62:269-273. © 2014 Wiley Periodicals, Inc.

journal_name

Pediatr Blood Cancer

journal_title

Pediatric blood & cancer

authors

Brinksma A,Roodbol PF,Sulkers E,Hooimeijer HL,Sauer PJ,van Sonderen E,de Bont ES,Tissing WJ

doi

10.1002/pbc.25301

subject

Has Abstract

pub_date

2015-02-01 00:00:00

pages

269-273

issue

2

eissn

1545-5009

issn

1545-5017

journal_volume

62

pub_type

杂志文章,评审

相关文献

PEDIATRIC BLOOD & CANCER文献大全
  • Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients.

    abstract：BACKGROUND:The optimal dose and schedule of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant recipients remains to be determined. We previously reported safety and pharmacokinetics of MMF at 900 mg/m2 q6h dosing. This study was conducted to investigate the efficacy of tacrolimus plus q8h MMF dos...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.27091

    authors： Militano O,Ozkaynak MF,Mehta B,van deVen C,Hamby C,Cairo MS

    更新日期：2018-08-01 00:00:00

  • Hypothalamic-pituitary function following childhood brain tumors: Analysis of prospective annual endocrine screening.

    abstract：BACKGROUND:Outcomes for childhood brain tumors are now associated with a five-year survival rate of 75%. Endocrine effects of brain tumors are common, occurring in 43% of patients by 10 years from tumor diagnosis. Optimal timing of screening for endocrinopathies remains undefined. We aim to identify incidence and timin...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.27631

    authors： Lawson SA,Horne VE,Golekoh MC,Hornung L,Burns KC,Fouladi M,Rose SR

    更新日期：2019-05-01 00:00:00

  • Late effects in childhood cancer survivors: a review with a framing effect bias?

    abstract：:Most publications report the adverse (negative) health issues in childhood cancer survivors. Presenting information to the newly diagnosed patient in a positive manner is advocated, while noting that recurrence is the most likely adverse event. Re-analysis of population-based studies on life-threatening toxicities fro...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.22975

    authors： Fryer C

    更新日期：2011-12-15 00:00:00

  • Diverse Cutaneous Presentations of Langerhans Cell Histiocytosis in Children: A Retrospective Cohort Study.

    abstract：BACKGROUND:Langerhans cell histiocytosis (LCH) is a rare disease, frequently affecting young children. PROCEDURE:We performed a retrospective study in patients younger than 16 years old manifesting with skin symptoms, and documented their different cutaneous lesions and systemic symptoms. We compared subgroups of chil...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25834

    authors： Morren MA,Vanden Broecke K,Vangeebergen L,Sillevis-Smitt JH,Van Den Berghe P,Hauben E,Jacobs S,Van Gool SW

    更新日期：2016-03-01 00:00:00

  • Bacteremia in febrile nonneutropenic pediatric oncology patients.

    abstract：BACKGROUND:We sought to determine the risk of bacteremia in a cohort of outpatient febrile nonneutropenic pediatric oncology patients and to assess clinical characteristics that may influence decisions regarding empiric antibiotic therapy. PROCEDURE:A single institution retrospective cohort study was performed of outp...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22264

    authors： Kelly MJ,Vivier PM,Panken TM,Schwartz CL

    更新日期：2010-01-01 00:00:00

  • The Italian consensus conference on the role of rehabilitation for children and adolescents with leukemia, central nervous system, and bone tumors, part 1: Review of the conference and presentation of consensus statements on rehabilitative evaluation of m

    abstract：:Because of increasing survival rates in pediatric oncology, attention is focusing on cancer and its treatment-related side effects. Rehabilitation may reduce their impact. However, the literature does not provide strong evidence regarding rehabilitation pathways. Therefore, the Italian Association of Pediatric Hematol...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.28681

    authors： Rossi F,Ricci F,Botti S,Bertin D,Breggiè S,Casalaz R,Cervo M,Ciullini P,Coppo M,Cornelli A,Esposito M,Ferrarese M,Ghetti M,Longo L,Morri M,Naretto G,Orsini N,Fagioli F,AIEOP Rehabilitation Working Group Members.

    更新日期：2020-12-01 00:00:00

  • If only I could turn back time-Regret in bereaved parents.

    abstract：INTRODUCTION:Regret about loss is one of the most intense types of regret experienced in life. Little is known about the bereavement regret of parents whose child has died of cancer. Although knowledge about parents' experiences after their child's death is vital for supporting these families, parents' regret is mostly...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28265

    authors： Sim CW,Heuse S,Weigel D,Kendel F

    更新日期：2020-06-01 00:00:00

  • Minor anomalies in children with hematological malignancies.

    abstract：BACKGROUND:Despite the presence of reports on correlation between major congenital defects and cancer, very few studies have investigated the frequency of minor anomalies in childhood malignancy. The aim of this study was to determine the prevalence of minor anomalies in children with hematological malignancy. PROCEDU...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22689

    authors： Citak FE,Citak EC,Akkaya E,Kosan B,Ezer U,Kurekci AE

    更新日期：2011-02-01 00:00:00

  • Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.

    abstract：BACKGROUND:For children with juvenile myelomonocytic leukemia (JMML) who undergo stem cell transplantation (SCT), the role of immunological interventions including withdrawal of immunosuppressive therapy (IST) and donor lymphocyte infusion (DLI) for treatment of disease recurrence remains uncertain. PROCEDURE:We analy...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24259

    authors： Inagaki J,Fukano R,Nishikawa T,Nakashima K,Sawa D,Ito N,Okamura J

    更新日期：2013-01-01 00:00:00

  • Cardiac liposarcoma and bilateral ovarian mature teratoma in a patient with congenital heart disease and f-anisosplenia.

    abstract：:A 10-year-old female with atrial septal defect presented with bilateral ovarian mature cystic teratomas. Three spleniculi adjacent to the main spleen were noticed while the endoscopic surgery. Two years later a heart tumor was discovered which led to death. Pathologic examination of samples of the mass proved it to be...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21487

    authors： Pollono DG,Drut R

    更新日期：2008-08-01 00:00:00

  • Proton therapy for pediatric head and neck malignancies.

    abstract：PURPOSE:Pediatric head and neck malignancies are managed with intensive multimodality therapy. Proton beam therapy (PBT) may reduce toxicity by limiting exposure of normal tissue to radiation. In this study, we report acute toxicities and early outcomes following PBT for pediatric head and neck malignancies. MATERIALS...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26858

    authors： Vogel J,Both S,Kirk M,Chao HH,Bagatell R,Li Y,Womer R,Balamuth N,Reilly A,Kurtz G,Lustig R,Tochner Z,Hill-Kayser C

    更新日期：2018-02-01 00:00:00

  • Leydig cell tumor after treatment for Ewing's sarcoma.

    abstract：:Leydig cell tumors account for 3% of testicular tumors and have never been reported after treatment for Ewing's sarcoma. We report the unusual occurrence of a patient who developed a Leydig cell tumor of the testis 18 years after successful treatment for Ewing's sarcoma. Additional monitoring for second malignancies m...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20825

    authors： Butros LJ,Phillip S,Chou A,Meyers PA,Huvos AG,Healey JH,Russo P,Gorlick RG

    更新日期：2007-12-01 00:00:00

  • Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high-dose chemotherapy: A single-center experience from the Royal Marsden Hospital, UK.

    abstract：BACKGROUND:Hepatic sinusoidal obstruction syndrome (SOS) is a serious complication of autologous stem cell transplant (ASCT) in children with historically high mortality rates. Defibrotide has shown proven benefit in its treatment and may have a modest role in prevention. We report our experience with SOS in children u...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.28677

    authors： Roy Moulik N,Johnson I,Van Bruggen L,Petterson T,Mycroft J,Vaidya SJ

    更新日期：2020-11-01 00:00:00

  • Prevalence of abnormal bone density of pediatric patients prior to blood or marrow transplant.

    abstract：:Osteoporosis and osteopenia are long-term side effects of bone marrow transplant (BMT). The purpose of this study was to determine the prevalence of bone mineral density (BMD) abnormalities in pediatric patients prior to BMT. Forty-four pediatric patients were evaluated with DEXA scans. The average Z-score was -0.37. ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.22102

    authors： Klopfenstein KJ,Clayton J,Rosselet R,Kerlin B,Termuhlen A,Gross T

    更新日期：2009-10-01 00:00:00

  • A single-center experience using alemtuzumab, fludarabine, melphalan, and thiotepa as conditioning for transplantation in pediatric patients with chronic granulomatous disease.

    abstract：:Chronic granulomatous disease (CGD) is an immune deficiency characterized by defective neutrophil function and increased risk of life-threatening infections. Allogeneic hematopoietic cell transplantation is curative for CGD, and conditioning regimen impacts transplant-related outcomes. We report a single-center prospe...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章

    doi：10.1002/pbc.28030

    authors： Bhatt ST,Schulz G,Hente M,Slater A,Murray L,Shenoy S,Bednarski JJ

    更新日期：2020-01-01 00:00:00

  • Pharmacokinetic interaction between methotrexate and chloral hydrate.

    abstract：:We report the case of a drug interaction between methotrexate (MTX) and chloral hydrate (CH) observed in a child treated for acute leukemia. Significantly slower MTX clearance and increased MTX exposure occurred on the first three courses of a high-dose chemotherapy when co-administered with CH despite normal renal fu...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24393

    authors： Dao K,Ivanyuk A,Buclin T,Beck-Popovic M,Diezi M

    更新日期：2013-03-01 00:00:00

  • Exploring barriers and facilitators to clinical trial enrollment in the context of sickle cell anemia and hydroxyurea.

    abstract：BACKGROUND:Several sickle cell clinical trials have closed due to inability to enroll patients. To limit the early cessation of a proposed clinical trial due to low accrual rates, we sought to better understand barriers and facilitators to enrolling parents of children with sickle cell anemia (SCD) into clinical trials...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,随机对照试验

    doi：10.1002/pbc.24486

    authors： Lebensburger JD,Sidonio RF,Debaun MR,Safford MM,Howard TH,Scarinci IC

    更新日期：2013-08-01 00:00:00

  • Addition of oral iron to plasma transfusion in human congenital hypotransferrinemia: A 10-year observational follow-up with the effects on hematological parameters and growth.

    abstract：:Congenital hypotransferrinemia (OMIM 209300) is an extremely rare disorder of inherited iron metabolism. Since its description in 1961, only 16 cases have been reported. The defective gene and molecular defect causing this disorder and clinicolaboratory findings seen in the homozygous and heterozygous states have been...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.26789

    authors： Aslan D

    更新日期：2018-02-01 00:00:00

  • Autologous stem cell transplantation for refractory opsoclonus myoclonus ataxia syndrome.

    abstract：:Opsoclonus, myoclonus, ataxia syndrome (OMA) is a severe neurologic disorder often associated with neuroblastoma. It is challenging to treat and can have long-term neurologic sequelae. Current recommended therapies include intravenous immunoglobulin, corticosteroids, rituximab, and chemotherapy (cyclophosphamide). We ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.27110

    authors： Johnston DL,Murray S,Irwin MS,Doyle J,Schechter T

    更新日期：2018-08-01 00:00:00

  • Perceived benefits and risks of participation in a clinical trial for Ugandan children with sickle cell anemia.

    abstract：INTRODUCTION:Understanding factors that affect the decisions of caregivers of African children to enroll their children in clinical trials would lead to more fully informed consent. METHODS:During the NOHARM study (NCT01976416), a placebo-controlled clinical trial of hydroxyurea for Ugandan children with sickle cell a...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.27830

    authors： Carman AS,Sautter C,Anyanwu JN,Ssemata AS,Opoka RO,Ware RE,Rujumba J,John CC

    更新日期：2020-02-01 00:00:00

  • Addressing implicit bias in pediatric hematology-oncology.

    abstract：:Although awareness of implicit bias and its influence on providers and patients is increasing, the effects of implicit bias on the field of pediatric hematology-oncology are less clear. This Special Report reviews the literature on implicit bias in pediatrics and medical oncology and further provides case examples and...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.28204

    authors： Tsai JW,Kesselheim JC

    更新日期：2020-05-01 00:00:00

  • Elevated mitochondrial DNA copy numbers in pediatric acute lymphoblastic leukemia: A potential biomarker for predicting inferior survival.

    abstract：BACKGROUND:Studies on mitochondrial DNA copy number reveal an increase or decrease in copy number that appears to be cancer specific, but data on acute lymphoblastic leukemia have been inconsistent regarding the significance of changes in mitochondrial DNA copies. The purpose of this pilot study was to analyze mitochon...

    journal_title：Pediatric blood & cancer

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1002/pbc.26874

    authors： Jain A,Bakhshi S,Thakkar H,Gerards M,Singh A

    更新日期：2018-03-01 00:00:00

  • Malignant ectomesenchymoma in children and adolescents: report from the Cooperative Weichteilsarkom Studiengruppe (CWS).

    abstract：BACKGROUND:Malignant ectomesenchymoma (MEM) is a soft tissue tumor with heterologous rhabdomyoblastic components believed to arise from pluripotent migratory neural crest cells. To date merely 50 cases have been published and the knowledge about the course of disease and optimal treatment is limited. METHODS:Six patie...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.24174

    authors： Dantonello TM,Leuschner I,Vokuhl C,Gfroerer S,Schuck A,Kube S,Nathrath M,Bernbeck B,Kaatsch P,Pal N,Ljungman G,Bielack SS,Klingebiel T,Koscielniak E,CWS.

    更新日期：2013-02-01 00:00:00

  • Extremely high birth prevalence of sickle cell disease in rural Tanzania.

    abstract：BACKGROUND/OBJECTIVES:Sickle cell disease (SCD) is an important, hidden cause of childhood mortality worldwide. It is most prevalent in sub-Saharan Africa where national newborn screening programs remain unavailable and most children in rural areas are never diagnosed. We conducted a study at a rural district hospital ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.28620

    authors： Eastburg L,Peckham A,Kawira E,Chirangi B,Adler D,Akungo BD,Smart LR,Ambrose EE

    更新日期：2020-11-01 00:00:00

  • Significant inconsistency among pediatric oncologists in the use of the neutropenic diet.

    abstract：BACKGROUND:The role of the neutropenic diet in the development of infections in oncology and stem cell transplant (SCT) patients is controversial. There is no data on the use of the neutropenic diet among pediatric oncologists. METHODS:A self-administered electronic survey was sent to 1,639 pediatric oncologists at 19...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.25104

    authors： Braun LE,Chen H,Frangoul H

    更新日期：2014-10-01 00:00:00

  • Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma.

    abstract：BACKGROUND:Positron emission tomography (PET) and gallium scans facilitate diagnosis and staging, evaluation of response to therapy, and monitoring for relapse in Hodgkin lymphoma (HL), but have not been compared in pediatric HL. PROCEDURE:We performed concurrent PET and gallium scans on 44 pediatric HL patients at di...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21574

    authors： Hines-Thomas M,Kaste SC,Hudson MM,Howard SC,Liu WA,Wu J,Kun LE,Shulkin BL,Krasin MJ,Metzger ML

    更新日期：2008-08-01 00:00:00

  • Testicular stem cells for fertility preservation: preclinical studies on male germ cell transplantation and testicular grafting.

    abstract：:Spermatogonial stem cells open novel strategies for preservation of testicular tissue and fertility preservation in boys and men exposed to gonadotoxic therapies. This review provides an update on the physiology of spermatogonial stem cells in rodent and primate testes. Species-specific differences must be considered ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章,评审

    doi：10.1002/pbc.22002

    authors： Schlatt S,Ehmcke J,Jahnukainen K

    更新日期：2009-08-01 00:00:00

  • Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.

    abstract：:Peripheral neuropathy is a well-known side effect of vincristine, a micro-tubule inhibitor commonly used to treat malignancies. Severe neurologic adverse events can occur in patients with Charcot-Marie-Tooth disease (CMT) treated with vincristine. Voriconazole is an antifungal agent used increasingly in children with ...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21786

    authors： Porter CC,Carver AE,Albano EA

    更新日期：2009-02-01 00:00:00

  • A case of natural killer cell lymphoma presenting with bilateral pleural effusions and hemophagocytic lymphohistocytosis.

    abstract：:Natural killer (NK) cell lymphoma of lung is very rare. We report a case of NK cell lymphoma presented in a 17-year-old male with bilateral pleural effusions and hemophagocytic lymphohistocytosis. Morphologic and immunohistochemical tests revealed an association of NK cell lymphoma with Epstein-Barr virus. A literatur...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.21943

    authors： Tai CF,Chang LY,Lin DT,Lin KH,Jou ST,Yang YL

    更新日期：2009-05-01 00:00:00

  • Polymorphism of angiotensin converting enzyme is associated with severe circulatory compromise in febrile neutropenic children with cancer.

    abstract：:Angiotensin converting enzyme (ACE) gene insertion(I)/deletion(D) polymorphism influences the outcome of a number of cardiovascular diseases. ACE I/D polymorphism was investigated by PCR in 207 pediatric cancer patients and 144 controls. ACE I/D distribution of patients and controls was similar. The frequency of the D...

    journal_title：Pediatric blood & cancer

    pub_type： 杂志文章

    doi：10.1002/pbc.20400

    authors： Bárdi E,Jenei C,Kiss C

    更新日期：2005-08-01 00:00:00